Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Iver Nordentoft(Aarhus University Hospital), Torben Ørntoft(Aarhus University Hospital), S. Høyer(Aarhus University Hospital), Philippe Lamy(Aarhus University Hospital), Niels Fristrup(Aarhus University), Malene Juul(Aarhus University Hospital), Søren Vang(Aarhus University Hospital), Kasper Thorsen(Aarhus University), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Karin Birkenkamp‐Demtröder(Aarhus University Hospital), Lars Dyrskjøt(Aarhus University Hospital), Thomas Reinert(Aarhus University Hospital), Andrew Roth(Canadian Centre for Applied Research in Cancer Control), Henrik Hornshøj(Aarhus University Hospital), Michael Borre(Aarhus University), Jakob Skou Pedersen(University of Copenhagen), Karey Shumansky(Canadian Centre for Applied Research in Cancer Control), Jakob Hedegaard(Aarhus University Hospital), Palle Villesen(Aarhus University)
Cited by 153
Related Papers
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654